Stonepine Capital Management’s Milestone Pharmaceuticals MIST Stock Holding History

Stonepine Capital Management’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-662,666	Closed	-$1.34M	–	95
2025 Q4	$1.34M	Buy	+662,666	New	+$1.43M	0.98%	31
2025 Q2	–	Sell	-250,000	Closed	-$200K	–	75
2025 Q1	$200K	Sell	250,000 -250,000	-50%	-$497K	0.19%	49
2024 Q4	$1.18M	Sell	500,000 -499,790	-50%	-$858K	0.95%	27
2024 Q3	$1.52M	Sell	999,790 -239,409	-19%	-$348K	0.96%	23
2024 Q2	$1.64M	Sell	1,239,199 -223,097	-15%	-$359K	1.49%	14
2024 Q1	$2.62M	Buy	+1,462,296	New	+$2.37M	2.08%	9

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Stonepine Capital Management's MIST Position: Q1 2026 in Review

Stonepine Capital Management sold out of Milestone Pharmaceuticals (MIST) in Q1 2026, closing a stake of 662,666 shares — an estimated $1.34M sold.

Stonepine Capital Management first reported a position in MIST in Q1 2024 and held it in 6 quarters. The position peaked at $2.62M in Q1 2024. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

Stonepine Capital Management reported no remaining Milestone Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Stonepine Capital Management sold 662,666 Milestone Pharmaceuticals shares in Q1 2026, an estimated $1.34M.
Stonepine Capital Management first reported a position in Milestone Pharmaceuticals in Q1 2024 and held it in 6 quarters.
Stonepine Capital Management's Milestone Pharmaceuticals position peaked at $2.62M in Q1 2024.
86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Stonepine Capital Management's 13F filing for Q1 2026, filed 14 May 2026.